F-star Therapeutics, Inc. FSTX
7.12 +7.12
Day range unavailable
52-week range unavailable
FSTX revenue history
Revenue is income from the company’s ordinary business activities.
21,167,000 USD
FY 2021 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | 21,167,000 | 9,911,000 | 88.05% |
| FY 2020 | 2020-12-31 | 11,256,000 | -17,065,000 | -60.26% |
| FY 2019 | 2019-12-31 | 28,321,000 | 28,321,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | -352,000 | -100.00% |
| FY 2016 | 2016-12-31 | 352,000 | -594,000 | -62.79% |
| FY 2015 | 2015-12-31 | 946,000 | 208,000 | 28.18% |
| FY 2014 | 2014-12-31 | 738,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.